Author Archives: Danzig

Biotech and beyond – The Hindu

Posted on by

When I was looking for universities to apply for an undergraduate programme, I heard about Rabindranath Tagore University (RNTU) and decided to visit the campus. I was astonished to see all the facilities offered here. Since the educational institutions in and around Vidisha dont offer similar facilities, I moved to Bhopal to join RNTU for a programme in Biotechnology.

This subject is used in different fields, including agriculture, environment and medicine and is slowly gaining popularity in India, especially in relation to agriculture, organic crops as well as cross breeding.

Infrastructure

At RNTU, we have access to excellent labs and equipment required for research, such as an in-house DNA fingerprinting lab and this makes the educational experience really engrossing.

Also, the teachers are supportive and helpful in creating an interactive learning experience. Presentations and audiovisual lessons and use of technology make the classes compelling.

The exposure to practical learning, as well as extracurricular activities, has improved my management and leadership skills. It has enabled me come out of my shell and explore the world as well as my own capabilities. One of my best experiences was representing my university at a national level debate competition organised by the Amity University, Lucknow.

In addition to participating in competitions, I was also a part of the volunteering committee at Vishwa Rang, the Tagore International Literature and Arts Festival during which I met and interacted with many artists and writers.

I was also a member of the organising team for the annual college festival Rhythm. We decided each act, divided the responsibilities and mapped of various activities with deadlines proper execution.

Even during the lockdown, we are constantly getting various internship opportunities so that our future is not adversely affected by the pandemic.

Kanika Soni is a third-year undergraduate student of Biotechnology from the Rabindranath Tagore University, Bhopal

You have reached your limit for free articles this month.

To get full access, please subscribe.

Already have an account ? Sign in

Show Less Plan

Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.

Move smoothly between articles as our pages load instantly.

Enjoy reading as many articles as you wish without any limitations.

A one-stop-shop for seeing the latest updates, and managing your preferences.

A select list of articles that match your interests and tastes.

We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Visit link:
Biotech and beyond - The Hindu

Surface functionalization: A tool for biotechnology and health sectors – Open Access Government

Posted on by

Case study 1: Nanoparticles as Oxygen Scavengers for food-packaging

Partners: University of Minho and International Iberian Nanotechnology Laboratory

Funding: Portuguese Foundation for Science and Technology (FCT) in the framework of the project NANOXYPACK co-financed via FEDER (PT2020) POCI-01-0145-FEDER-030789.

The development of oxygen-sensitive and detecting materials is one of the main aims in the packaging industry, as even a 2% residual oxygen concentration may alter food organoleptic properties. The presence of oxygen in the packaging, as well as the permeation of oxygen during storage, is then avoided by using oxygen scavenging materials and controlled by using packaging materials with low permeability to gases.

This project addresses the development of a new generation of active and intelligent packaging film for foods through the dispersion of nano-sized multifunctional particles (Figure 1) incorporated by magnetron sputtering onto a bio-polymeric matrix.The enhanced oxygen absorption capacity, antimicrobial properties and changes in colour as a function of oxygen absorption provide the packagingmaterial with the multifunctional characteristics required to enlarge the shelf-life of the food.

Partners: University of Minho and University of Porto and DENTAL VERDE CLNICA MDICA E DENTRIA, LDA

Funding: Portuguese Foundation for Science and Technology (FCT) in the framework of the HEALTHYDENT (co-financed via FEDER (PT2020) POCI-01-0145-FEDER-030708

The HEALTHYDENT project develops a new concept of dental implants. A novel surface with graded functional treatments will give a solution for the main problems of dental implants used nowadays: Poor bioactivity that delays osseintegration, and periimplantitis, an inflammatory disease due to bacterial infection.

The strategy to achieve this novel design was accomplished in two main steps. As first step, tantalum surface functionalization was carried out by micro-arc oxidation (also called plasma electrolytic oxidation, an electrochemical process derived from anodization) to create a porous tantalum oxide (Ta2O5) surface enriched with calcium and phosphorous in order to mimic the morphology and chemical composition of the bone tissue (Figure 2-A). Secondly, this enriched porous Ta2O5 surface was doped with zinc (Zn) nanoparticles (Figure 2-B), by DC magneton sputtering technique providing the antibacterial ability. As it is crucial to guarantee the balance between the non-toxicity of the Zn nanoparticles and the bacterial inhibition, an additional carbon layer was deposited after Zn nanoparticles deposition (Figure 2- C, D and E).

The biological response of the modified surface was evaluated, and it was observed that the surface functionalization did not show toxicity, as shown by the MTT assay for the sample with Zn nanoparticles and the sample with Zn nanoparticles and the carbon layer (Figure 3-A and B, respectively) and by the cells adhesion and proliferation in both surfaces (Figure 3- C and D, respectively). It is important highlight that the sample with the Zn nanoparticles revealed a more efficient ability to inhibit the bacteria adhesion than the surface functionalization with the Zn nanoparticles and the carbon layer, Figure 3-E and F, respectively.

Partners: University of Minho, University of Coimbra and ICC-Indstrias e Comrcio de Calado S.A

Funding: Science DiabetICC Footwear POCI-01-0247-FEDER-039784

Science DiabetICC Footwear project proposes the development of a new typology of footwear oriented to the segments of therapeutic footwear targeting the clinical condition of Diabetic Foot (DF). The solution consists of components of the footwear and a removable insole, adding the ability to reduce the risk of ulcer-associated infections. In this context, at the insoles level, antimicrobial coatings deposited by magnetron sputtering were developed, aiming to prevent the occurrence of infections resulting from DF.

In vitro antimicrobial activity was assessed using a yeast Candida parapsilosis and a bacterium Staphylococcus epidermidis commonly found on the skin. Different coatings were tested, and the AgO-0.25 coating was the one that showed the best results, it has a greater halo around the sample (transparent zone indicating the absence of microorganisms) as can be seen in figure 4 and through the SEM images obtained after the test, the original leather contains microorganisms, contrary to the one coated with AgO.

*Please note: This is a commercial profile

Editor's Recommended Articles

See the article here:
Surface functionalization: A tool for biotechnology and health sectors - Open Access Government

Debut Biotechnology Awarded $1M from Air Force Research Lab to Leverage Cell-Free Continuous Biomanufacturing in Aerospace Applications – PR Web

Posted on by

Debut Bio

SAN DIEGO (PRWEB) September 15, 2020

Debut Biotechnology, a UC-Irvine spinout advancing scalable cell-free biomanufacturing, today announced that it has been awarded $1M from the Air Force Research Labs Biotechnology Grand Challenge. Debut Bio is the inaugural recipient of the award, which honors the companys proposal on biosynthesis of monomers for aerospace applications.

In the proposal, Debut Bio details its ability to leverage the companys scalable biomanufacturing platform for bio- and metal-free synthesis of polymer precursors relevant for the aerospace industry. Debut Bios platform will provide AFRL with the ability to effectively and efficiently biomanufacture specialty ingredients needed for aerospace applications. In doing so, Debut Bio expects to reduce aerospace material costs and improve vehicle maintenance processes by extending service lifetimes.

The Air Force Research Lab has a well-documented history in discovering and leveraging breakthrough technologies. By offering a cell-free, continuous biomanufacturing process, we are excited to continue that legacy of innovation through our work with them, said Dr. Joshua Britton, CEO and Founder of Debut Biotechnology. Cell-free biomanufacturing enables the quality manufacturing of high-value molecules at a price point that scales far beyond what is possible today. In bringing this approach to the AFRL, we hope to usher in a new era of biomanufacturing for high-value molecules that is scalable, economically viable, and results in solutions that are efficient and effective.

Debut Bio has applied its technology to the pharmaceutical and specialty ingredient industries, allowing customers to manufacture high-value molecules by combining custom-designed immobilized enzymes with continuous biomanufacturing processes. Through the utilization of plug-and-play enzyme cartridges, the companys cell-free platform has the ability to transform low-value bio-renewable materials into high-value specialty chemicals.

The Debut Biotechnology proposal provides a path to a scalable, bio- and metal free synthesis of key aerospace polymer precursors, explained Dr. Davide Simone, AFRLs technology advisor for biosynthesis of monomers for aerospace thermosets and senior research chemist. Expected benefits for the Air Force include a significant savings in composite aerospace structural material costs and the elimination of oxidation promoting metal catalysts from structural components, extending service lifetimes.

Debut Bios enzyme cartridges are sequentially arranged in a manner which mimics pathways found in plants and other organisms. Each cartridge is finely-tuned to provide the ideal temperature, pH, concentration, solvent, and reaction time for each individual step to maximize enzymatic productivity and product titer levels. The platform requires far fewer steps than traditional materials manufacturing and avoids the use of environmentally harmful chemical synthesis. Importantly, it overcomes many challenges typically associated with relying on cells for biomanufacturing or extraction of ingredients from plants and other sources.

In Debut Bios system, materials are passed from one enzyme reactor to another to build in-vitro or cell-free biosynthetic pathways. The companys platform uses a sustainable approach by leveraging advanced enzymes outside of the cell to maximize performance and avoid issues with cell-based fermentation systems. The platform technology operates under a continuous manufacturing regime, allowing Debut Bio to scale beyond the capabilities of other manufacturing processes currently on the market, which are constrained by the precipitation of enzymes, the need for multiple large reactors, and the specific requirements of enzymes. By leveraging continuous manufacturing, Debut Bio is able to drive down the cost of cell-free manufacturing to provide scale, consistency, novelty, and ultimately the ability to produce a biomolecule with the click of a button.

Debut Bio serves organizations across the defense and specialty ingredient industries, with commitments from several large scale manufacturers to integrate its platform into their existing pipelines.

To learn more, please visit: https://debutbiotech.com.

About Debut Biotechnology

Debut Biotechnology is commercializing cell-free biomanufacturing solutions by creating advanced enzyme-based manufacturing processes for high-value molecules. Our platform combines immobilized enzymes with highly controlled and automated continuous manufacturing systems for the pharmaceutical and specialty chemical industries.

Debut Biotechnology was founded by Joshua Britton, Greg Weiss, and Brady Beauchamp and is based in sunny San Diego. To learn more, please visit: https://debutbiotech.com/.

Share article on social media or email:

Continued here:
Debut Biotechnology Awarded $1M from Air Force Research Lab to Leverage Cell-Free Continuous Biomanufacturing in Aerospace Applications - PR Web

Agricultural Biotechnology Market Research, Recent Trends and Growth Forecast 2026 – theresearchprocess.com

Posted on by

This market study on A2P SMS Market covers the global and regional market with an in-depth breakdown of the inclusive growth prospects in the market. Also, it sheds light on the wide-ranging competitive landscape of the global A2P SMS market. The report supplementary offers a dashboard overview of leading companies with their successful marketing strategies, market contribution, recent developments in both historic and present contexts. The A2P SMS Market analysis includes the global market by value, by segments and by competitors overall advancement and strategies.

The report provides insights on the following sections:

Request Sample Copy of this Report @ https://www.theresearchprocess.com/request-sample/4613

Global A2P SMS industry profile provides top-line qualitative and quantifiable information including: A2P SMS market share, market size. The profile also contains descriptions of the foremost players including key financial metrics and analysis of competitive pressures within the A2P SMS market. Essential resource for top-line data and analysis covering the global A2P SMS market. Includes A2P SMS market size and segmentation data, textual and graphical analysis of A2P SMS market growth trends and leading companies.

Request Sample Copy of this Report @ https://www.theresearchprocess.com/request-sample/4613

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

Some of the Highlights about Table of Content of A2P SMS Market

1 A2P SMS Market overview

2 Executive Summary

3 Market Drivers, Challenges and Trends

4 Marketing, Distributors and Customer

5 Key Players Analysis

Request Customization on This Report @ https://www.theresearchprocess.com/request-for-customization/4613

Read more:
Agricultural Biotechnology Market Research, Recent Trends and Growth Forecast 2026 - theresearchprocess.com

Where Does Nantkwest Inc (NK) Stock Fall in the Biotechnology Field? – InvestorsObserver

Posted on by

Nantkwest Inc (NK) is around the top of the Biotechnology industry according to InvestorsObserver. NK received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Nantkwest Inc also achieved a score of 79 in the Biotechnology industry, putting it above 79 percent of Biotechnology stocks. Biotechnology is ranked 31 out of the 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 62 means the stock is more attractive than 62 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Nantkwest Inc (NK) stock is trading at $7.94 as of 1:12 PM on Monday, Sep 14, a gain of $1.34, or 20.3% from the previous closing price of $6.60. The stock has traded between $6.84 and $7.97 so far today. Volume today is above average. So far 1,740,191 shares have traded compared to average volume of 1,370,495 shares.

Click Here to get the full Stock Score Report on Nantkwest Inc (NK) Stock.

View post:
Where Does Nantkwest Inc (NK) Stock Fall in the Biotechnology Field? - InvestorsObserver

Global Biochemical Diagnostic Reagent Market Insights and Forecast 2020 to 2025 – The Daily Chronicle

Posted on by

This report additionally covers the effect of COVID-19 on the worldwide market. The pandemic brought about by Coronavirus (COVID-19) has influenced each part of life all inclusive, including the business segment. This has brought along a several changes in economic situations.

The Biochemical Diagnostic Reagent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

It incorporates Biochemical Diagnostic Reagent market evolution study, involving the current scenario, growth rate (CAGR), and SWOT analysis. Important the study on Biochemical Diagnostic Reagent market takes a closer look at the top market performers and monitors the strategies that have enabled them to occupy a strong foothold in the market. Apart from this, the research brings to light real-time data about opportunities that will completely transform the trajectory of the business environment in the coming years to 2025. Some of the key players in the global Biochemical Diagnostic Reagent market is cccc

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ http://marketresearchbazaar.com/requestSample/61377

According to 99Strategy, the Global Biochemical Diagnostic Reagent Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Biochemical Diagnostic Reagent market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Roche

Siemens Healthineers

Beckman Coulter

Randox

BioSino

Beijing Leadman Biochemistry

FosunPharma

Beijing Strong Biotechnologies

Dojindo Laboratories

Sysmex

KAINOS Laboratories

DAAN Gene

Key Product Type

Liquid Double Reagent

Dry Powder Double Reagent

Market by Application

Hospital

Clinic

Laboratory

Main Aspects covered in the Report

Overview of the Biochemical Diagnostic Reagent market including production, consumption, status & forecast and market growth

2016-2020 historical data and 2021-2026 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

Impact of Coronavirus on the Industry

Enquiry Before Buying: http://marketresearchbazaar.com/enquiry/61377

Major Point of TOC:

Chapter One: Biochemical Diagnostic Reagent Market Overview

Chapter Two: Biochemical Diagnostic Reagent Market Segment Analysis by Player

Chapter Three: Biochemical Diagnostic Reagent Market Segment Analysis by Type

Chapter Four: Biochemical Diagnostic Reagent Market Segment Analysis by Application

Chapter Five: Biochemical Diagnostic Reagent Market Segment Analysis by Sales Channel

Chapter Six: Biochemical Diagnostic Reagent Market Segment Analysis by Region

Chapter Seven: Profile of Leading Biochemical Diagnostic Reagent Players

Chapter Eight: Upstream and Downstream Analysis of Biochemical Diagnostic Reagent

Chapter Nine: Development Trend of Biochemical Diagnostic Reagent (2020-2029)

Chapter Ten: Appendix

Read Full Report: http://marketresearchbazaar.com/requestSample//detail/61377

If you have any special requirements, please let us know and we will offer you the report as you want.

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

UK: +442070973908

US: +13156360953

India: +919548234540

Email:[emailprotected]

Website:http://marketresearchbazaar.com/

Blog:http://marketresearchbazaar.com/blogs

Follows to Twitter :https://twitter.com/BazaarMrb

Follows to Linkdin :https://www.linkedin.com/company/market-research-bazaar-vrrb/

See the original post:
Global Biochemical Diagnostic Reagent Market Insights and Forecast 2020 to 2025 - The Daily Chronicle

The Immigrants Who Created New Possibilities – The Atlantic

Posted on by

Barack Obamas father has a story like Donald Harriss. In 1959, with Kenya on the verge of independence, the nationalist leader Tom Mboya hatched a scheme to send talented young Kenyans to Western universities so they could return and help run the fledgling country. The British colonial authorities dismissed the idea because a British-affiliated university was next door in Uganda. So Mboya went to the U.S., where he raised funds from Harry Belafonte, Sidney Poitier, and Jackie Robinson, and, later, from presidential candidate John F. Kennedy, who thought the plan might make Kenyas emerging elite pro-American. One of the students who won Mboyas scholarship was Barack Obama Sr., who met Ann Dunham, the future presidents mother, in a Russian class at the University of Hawaii in 1960.

Read: The real story of Obamas mom

Gopalan, Harris, and Obama Sr. were ahead of their time. In the early 1960s, the U.S. permitted few immigrants from Africa and Asia. But that changed with the 1965 Immigration and Nationality Act, which opened Americas doors to newcomers who werent from northern Europe. From 1965 to 1970, the number of immigrants from Asia quadrupled. Immigration from the Caribbean was almost four times higher in the 1960s than it had been in the 1950s. And the number of international students in the U.S.many of whom stayed in the country after receiving their degreesbegan a steady climb from fewer than 100,000 in the late 1950s to 400,000 by the late 1980s to more than 1 million by the time Trump took office. In 2016, nine of the 10 countries that sent the most students to the U.S. were in Asia, Africa, or the Middle East.

Supporters of these trends often defend them in economic terms. Immigrants, they note, are responsible for many of the patents created by Americas top research universities. Foreign students tuition subsidizes public universities during an era in which state-government support has dwindled. And many foreign students go on to create companies that employ Americans.

But theres an asymmetry between establishment pro-immigration voices, who generally stress materialist arguments, and the conservative nationalists, ascendant under Trump, who define immigration primarily as a political, cultural, and racial threat. In her book, Adios America, which helped shape Trumps immigration message in 2016, Ann Coulter depicts the 1965 immigration law as part of a progressive strategy to flood the United States with nonwhite immigrants so that conservatives cant win elections. Democrats had not been able to get a majority of white people to vote for them, she writes. Their only hope was to bring in new voters.

This line of argument reduces immigration to an electoral ploy, and Democrats often respond by stressing the utilitarian benefits of welcoming people from all over. But the very existence of Kamala Harris and Barack Obama reveals a political effect that cant be captured by statistical generalizations. Immigration into the United States allows multicultural interactions that produce Americans who can see the country from both within and without.

View post:
The Immigrants Who Created New Possibilities - The Atlantic

Increase In Frequency Of Product Innovations To Drive The Biochemistry Analyser Market From 2024 – The Daily Chronicle

Posted on by

Market Size US$ 4,700 Mnin 2024, Market Growth CAGR of 5.5%, Market Trends Growing prevalence ofHealthcare Industry

The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. In addition to this, accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe. Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors.

A recent report published by Persistence Market Research projects that by the end of 2024, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/6451

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/6451

Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction.

The report current values the globalbiochemistry analyzer marketat a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.

Key Research Insights from the Report include:

The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024

Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patients metabolic functions

Access Full Report @ https://www.persistencemarketresearch.com/checkout/6451

Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America

Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR

Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers a cost-effective upgrade to existing product line

The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers.

Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR.

The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website https://www.persistencemarketresearch.com

Continued here:
Increase In Frequency Of Product Innovations To Drive The Biochemistry Analyser Market From 2024 - The Daily Chronicle

Global Veterinary Biochemistry Analyzers Market: Industry Development Scenario and Forecast to 2025 – express-journal.com

Posted on by

The report on Veterinary Biochemistry Analyzers market offers a comprehensive analysis of this business sphere, elucidating the key growth indicators, opportunities, and limitations to assist companies with effective decision making for further business expansion.

The document also investigates the fluctuations in the supply & demand channels caused due to the outbreak of the COVID-19 pandemic. It further analyses the ever-changing competitive framework by analyzing the strategies employed by them.

Major highlights from COVID-19 impact analysis:

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/198780

Regional analysis:

Additional highlights from the Veterinary Biochemistry Analyzers market report:

This Veterinary Biochemistry Analyzers Market Research/analysis Report Contains Answers To Your Following Questions:

Why to Select This Report:

The research process begins with internal and external sources to obtain qualitative and quantitative information related to the Veterinary Biochemistry Analyzers market. It also provides an overview and forecast for the Veterinary Biochemistry Analyzers market based on all the segmentation provided for the global region. The predictions highlighted in the Veterinary Biochemistry Analyzers market share report have been derived using verified research procedures and assumptions. By doing so, the research report serves as a repository of analysis and information for every component of the Veterinary Biochemistry Analyzers market.

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/198780

Link:
Global Veterinary Biochemistry Analyzers Market: Industry Development Scenario and Forecast to 2025 - express-journal.com

Global Biochemical Methane Market Report Global Industry Size, Segment By Key Companies, Types & Applications And Forecast To 2025 (Five Years…

Posted on by

Biochemical Methane Markethas been riding a progressive growth trail over the recent past. The first two quarters of the year 2020 have however witnessed heavy disruptions throughout all the industry facets, which are ultimately posing an unprecedented impact onBiochemical Methane market. Although healthcare & life sciences industry as a whole is witnessing an influx of opportunities in selected sectors, it remains a matter of fact that some of the industry sectors have temporarily scaled back. It becomes imperative to stay abreast of all the recent updates and predict the near future wisely.

The report primarily attempts to track the evolution of growth path of market from 2019, through 2020, and post the crisis. It also provides long-term market growth projections for a predefined period of assessment, 2020 2025. Based on detailed analysis of industrys key dynamics and segmental performance, the report offers an extensive assessment of demand, supply, and manufacturing scenario. Upsurge in R&D investments, increasing sophistication of healthcare infrastructure, thriving medical tourism, and rapidly introducing innovations in Biochemical Methane and equipment sector are thoroughly evaluated.

NOTE: Our team is studying Covid-19 impact analysis on various industry verticals and Country Level impact for a better analysis of markets and industries. The 2020 latest edition of this report is entitled to provide additional commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry.

Request Free Sample Report Biochemical Methane industry outlook @ Key players in the global Biochemical Methane market covered in Chapter 4: EnviTec Biogas AG (DE), MagneGas (US), SGN (UK), PlanET Biogas Global GmbH (DE), Verbio (DE), Gasrec Ltd. (UK), Biogas Products Ltd. (UK), Future Biogas Limited (UK), CNG Services Ltd (UK), Gazasia Ltd (UK), J V Energen (UK), Schmack Carbotech GmbH (DE), Orbital Gas Systems (US), SoCalGas (US), ETW Energietechnik GmbH (DE)

In Chapter 11 and 13.3, on the basis of types, the Biochemical Methane market from 2020 to 2025 is primarily split into:Organic Household WasteAnimal ManureEnergy CropsAgricultural WasteSewage SludgeIndustrial Food Processing WasteOthers

In Chapter 12 and 13.4, on the basis of applications, the Biochemical Methane market from 2020 to 2025 covers:Power GenerationAutomotiveOthers

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

United States, Canada, Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia, Brazil, Mexico, Argentina, Columbia, Chile, Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of the World

Some Points from Table of Content

Global Biochemical Methane Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026

Chapter 1Report Overview

Chapter 2Global Market Growth Trends

Chapter 3Value Chain of Biochemical Methane Market

Chapter 4Players Profiles

Chapter 5Global Biochemical Methane Market Analysis by Regions

Chapter 6North America Biochemical Methane Market Analysis by Countries

Chapter 7Europe Biochemical Methane Market Analysis by Countries

Chapter 8Asia-Pacific Biochemical Methane Market Analysis by Countries

Chapter 9Middle East and Africa Biochemical Methane Market Analysis by Countries

Chapter 10South America Biochemical Methane Market Analysis by Countries

Chapter 11Global Biochemical Methane Market Segment by Types

Chapter 12Global Biochemical Methane Market Segment by Applications

Chapter 13Biochemical Methane Market Forecast by Regions (2020-2026)

Chapter 14Appendix

Impact of Covid-19 in Biochemical Methane Market: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biochemical Methane market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Points Covered in the Report

>>>>Get Full Customize report @ https://www.reporthive.com/request_customization/2413703

Get in Touch with Us :Report Hive Research500, North Michigan Avenue,Suite 6014,Chicago, IL 60611,United StatesWebsite: : https://www.reporthive.comEmail: [emailprotected]

View post:
Global Biochemical Methane Market Report Global Industry Size, Segment By Key Companies, Types & Applications And Forecast To 2025 (Five Years...

Immunomic Therapeutics to Participate at World Vaccine Congress Washington 2020 – Business Wire

Posted on by

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI) announced today that it will participate at the World Vaccine Congress Washington being held virtually September 28-October 1, 2020. Andrew Eisen, MD, Ph.D., Immunomics Vice President of Clinical Development, will present a talk titled, Pharmacodynamic Imaging in a CMV Vaccine Trial for Glioblastoma.

In addition, Immunomic Therapeutics, lead founder and supporter of Why We Vax, a non-profit whose mission is to help educate communities with research backed facts on vaccines, will be leading a Q&A panel titled, What If They Gave a COVID-19 Vaccine and Nobody Came, at 3:50pm EST on October 1, 2020.

Vaccines are one of the safest, most widely-adopted health care practices in the world. Why We Vax will spread the message that vaccines are rigorously tested and provide the best defense against diseases. One example is Measles, which can have a lasting impact on a childs immune system, said Dr. William Hearl, Why We Vax Chairman, Immunomic Therapeutics CEO, and experienced vaccinologist.

The World Vaccine Congress Washington is a multi-faceted conference experience with over 300 industry leading speakers, exclusive interviews, world leading presentations, live panel debates, and virtual face to face meetings.

Presentation details are as follows:

Dr. Andrew Eisen PresentationTitle: Pharmacodynamic Imaging In A CMV Vaccine Trial For GBMPanel Category: Cancer and Immunotherapy TrackPanel Date and Time: Wednesday, September 30, 2020 2:30PM

Why We Vax Q&A PanelTitle: What If They Gave a COVID-19 Vaccine and Nobody CameCategory: Vaccine Safety track: Risk Assessment & Communication of SafetyDate and Time: Thursday, October 1, 2020 3:50PM

About UNITE

ITIs investigational UNITE platform, or UNiversal Intracellular Targeted Expression, is thought to work by encoding the Lysosomal Associated Membrane Protein, an endogenous protein in humans. In this way, ITIs vaccines (DNA or RNA) have the potential to utilize the bodys natural biochemistry to develop a broad immune response including antibody production, cytokine release and critical immunological memory. This approach could put UNITE technology at the crossroads of immunotherapies in a number of illnesses, including cancer, allergy and infectious diseases. UNITE is currently being employed in Phase II clinical trials as a cancer immunotherapy. ITI is also collaborating with academic centers and biotechnology companies to study the use of UNITE in cancer types of high mortality, including cases where there are limited treatment options like glioblastoma and acute myeloid leukemia. ITI believes that these early clinical studies may provide a proof of concept for UNITE therapy in cancer, and if successful, set the stage for future studies, including combinations in these tumor types and others. Preclinical data is currently being developed to explore whether LAMP nucleic acid constructs may amplify and activate the immune response in highly immunogenic tumor types and be used to create immune responses to tumor types that otherwise do not provoke an immune response.

About ITI-1000 and the Phase 2 (ATTAC-II) Study

ITI-1000 is an investigational dendritic cell vaccine therapy currently in a Phase 2 clinical trial (ATTAC-II) for the treatment of GBM. ITI-1000 was developed using Immunomics proprietary investigational lysosomal targeting technology, UNITE, in the context of cell therapy. In May 2017, Immunomic exclusively licensed a patent portfolio from Annias Immunotherapeutics for use in combination with UNITE and ITI-1000, allowing Immunomic to combine UNITE with a patented and proprietary CMV immunotherapy platform. The ATTAC-II study (NCT02465268) is a Phase II randomized, placebo-controlled clinical trial enrolling patients with newly diagnosed GBM that will explore whether dendritic cell (DC) vaccines, including ITI-1000, targeting the CMV antigen pp65 improves survival. This study is enrolling up to 120 subjects at 3 clinical sites in the United States. For more information on the ATTAC-II study, please visit http://www.clinicaltrials.gov.

About Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical stage biotechnology company pioneering the development of vaccines through its proprietary investigational technology platform, UNiversal Intracellular Targeted Expression (UNITE), which is designed to utilize the bodys natural biochemistry to develop vaccines that generate broad immune responses. UNITE has a robust history of applications in various therapeutic areas, including infectious diseases, oncology, allergy and autoimmune diseases. ITI is primarily focused on applying the UNITE platform to oncology, where it could potentially have broad applications, including viral antigens, cancer antigens, neoantigens and antigen-derived antibodies as biologics. The Company has built a large pipeline from UNITE with six oncology programs and two allergy programs. ITI has entered into a significant allergy partnership with Astellas Pharma and has formed several academic collaborations with leading Immuno-oncology researchers at Fred Hutchinson Cancer Research Institute, Johns Hopkins University of Medicine, and Duke University. ITI maintains its headquarters in Rockville, Maryland. For more information, please visit http://www.immunomix.com.

View post:
Immunomic Therapeutics to Participate at World Vaccine Congress Washington 2020 - Business Wire

Drilling Tools Market Size Scope and Comprehensive Analysis by 2028 – The Daily Chronicle

Posted on by

This detailed market report focuses on data from different primary and secondary sources, and is analysed using various tools. It helps gives insights into the markets growth potential, which can help investors identify scope and opportunities. The analysis also provides details of each segment in the global Drilling Tools Market.

Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-62056?utm_source=TDC/SSK

The Drilling Tools market report highlights market opportunities and competitive scenarios for Drilling Tools on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the Drilling Tools market. Also, key factors impacting the growth of the Drilling Tools market have been identified with potential gravity.

The prominent players covered in this report: Schlumberger, National Oilwell Varco, Halliburton, BHGE, Weatherford, Transocean, Nabors, Helmerich & Payne, Shell, Chevron, ExxonMobil, British Petroleum, Saudi Aramco, Petrobras, Petronas.

The market is segmented into By Type (Drill Bits, Drilling Tubulars, Drilling Motors, Drill Reamers and Stabilizers, Drill Collars, Drill Jars, Drill Swivels, Mechanical Thrusters), By Application (Onshore and Offshore).

Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, And South America.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-62056?utm_source=TDC/SSK

Highlighted points of Drilling Tools market that covers the varying market dynamics of the industry:

This report on Drilling Tools market contains Answers to the following Questions:

Make an Enquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-62056?utm_source=TDC/SSK

About Us:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [emailprotected]

Web: https://www.quincemarketinsights.com

Go here to see the original:
Drilling Tools Market Size Scope and Comprehensive Analysis by 2028 - The Daily Chronicle

Biochemical Reagents Market Revenue, Growth Rate, Customer Needs, Trend, Manufacturers and Forecast to 2025 – express-journal.com

Posted on by

The report on Biochemical Reagents market offers a comprehensive analysis of this business sphere, elucidating the key growth indicators, opportunities, and limitations to assist companies with effective decision making for further business expansion.

The document also investigates the fluctuations in the supply & demand channels caused due to the outbreak of the COVID-19 pandemic. It further analyses the ever-changing competitive framework by analyzing the strategies employed by them.

Major highlights from COVID-19 impact analysis:

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/200720

Regional analysis:

Additional highlights from the Biochemical Reagents market report:

This Biochemical Reagents Market Research/analysis Report Contains Answers To Your Following Questions:

Why to Select This Report:

The research process begins with internal and external sources to obtain qualitative and quantitative information related to the Biochemical Reagents market. It also provides an overview and forecast for the Biochemical Reagents market based on all the segmentation provided for the global region. The predictions highlighted in the Biochemical Reagents market share report have been derived using verified research procedures and assumptions. By doing so, the research report serves as a repository of analysis and information for every component of the Biochemical Reagents market.

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/200720

View original post here:
Biochemical Reagents Market Revenue, Growth Rate, Customer Needs, Trend, Manufacturers and Forecast to 2025 - express-journal.com

Department of Energy Awards $1M to CU Denver-Led Team for Computational Biology – CU Denver News

Posted on by

The U.S. Department of Energy (DOE) announced $5 million in funding for six new research projects in computational biology, $1,049,639 of which goes to Chris Miller, associate professor in CU Denvers Department of Integrative Biology, and his collaboratorsFarnoush Banaei-Kashani from CU Denver, Kelly Wrighton from CSU, and Chris Henry from DOE.

Millers project, titled Finding the Missing Pieces: Filling Gaps that Impede the Translation of Omics Data into Models, seeks to develop novel computational biology approaches and software to better understand microbial genomes relevant to the environment. According to Miller, there are parallels to studying the human microbiome in many challenges we see todayclimate change, bioenergy-relevant systems, and more.

Take, for example, a freshwater wetland system in Ohio. Miller and his colleagues studied this model for years because microbes in the soil of freshwater wetlands naturally emit the greenhouse gas methane. All that said, we know relatively little about the controls on this microbial process or how changing climate or land-use practices might affect emissions.

There are thousands of different types of microbes (bacteria, fungi, etc.) living in even just a pinch of this soil, Miller said. But we have no clue how to grow and study most of them in the lab, so DNA sequencing and computation give us the ability to extract DNA directly from soil, sequence the bits of genome we recover, and then computationally try to piece the original genomes back together.

The reason this matters? Miller notes by following this process, we are able to actually predict which proteins those genomes encode and infer what the microbes might be doing in the environment.

In some of these complex soils, we are discovering novel organismslots of themand the genes we are sequencing often look nothing like scientists have characterized in the lab before, Miller said. New computational approaches are needed to infer microbial biochemistry and metabolism from the DNA so we can better understand and predict microbial roles in the larger ecosystems.

By developing new algorithms and software for analyzing microbial genomes recovered from the environment, Miller and his team will develop and scale new computational methods to infer functions for genes. This will be integrated into a DOE computational biology system called KBase so scientists all over the world can utilize their methods to more efficiently figure out what proteins and genomes are doing in their systems of interest.

This project is exciting because it is foundational to answering so many different kinds of questions, said Miller. Biology is increasingly Big Data science, and we need to make sure we have the computational tools to keep up with the data generation Our collaborators on this project are world-class, and I feel grateful that CU Denver students and I will have the chance to work with and learn from this team to advance the science.

Related Research: Genetic Adaptation to Climate Change Is Swift in Crop Pests

Awards were selected based on competitive peer review under a DOE Funding Opportunity Announcement issued by the Office of Biological and Environmental Research (BER) within DOEs Office of Science. Total funding is $5 million in Fiscal Year 2020 dollars, for projects up to three years in duration.

A list of projects can be found on the BER homepage under the heading, Whats New.

See original here:
Department of Energy Awards $1M to CU Denver-Led Team for Computational Biology - CU Denver News

Heparin Sodium Market Estimated to be driven by Innovation and Industrialization – The Daily Chronicle

Posted on by

The Heparin Sodium industry research report is improved with the current effect realized through COVID-19 on the business. The report has been scrupulously studied and the data has been speculated in view with the present pandemic shock that the world has witnessed- market brief, dynamics, trends, and upcoming profit openings.

The report details future forecasts for the industry for the year 2020, for example, CAGR, market share, size, demand and consumption rate, and manufacturing competence of the voluminous key contenders. Moving forth, Heparin Sodium research investigation provides market data, entailing trends, consumer behavior, and combative landscape in a way that permits individuals and businesses to classify potential growth throughout the worldwide markets.

Market Major Companies: Shenzhen Hepalink, Nanjing King-friend, Changzhou Qianhong Bio-pharma, Changshan Biochemical, Dongying Tiandong Pharmaceutical, Xinbai Pharmaceuticals, SPL, Bioibrica, Baxter, Dongcheng Biochemicals, Opocrin, Aspen Oss, Pharma Action, Pfizer

Market Segment via Product type: Electric Type, Hydraulic Type, Hybrid Type,

Strategic Heparin Sodium applications along with their consumption forecast details: Treatment of Venous Thromboembolism, Complications of Pregnancy, Cardioversion of Atrial Fibrillation/Flutter,

Download Complimentary Sample of Heparin Sodium Market @ https://www.regalintelligence.com/request-sample/107909

The eminent challengers incorporated in the report:

Heparin Sodium Market research report contributes extensive knowledge with the specialized investigation for the timeline 2020-2024. The report shares details of upstream raw materials, downstream requirements, and production value through some significant elements subject to market growth.

The timeline considered to evaluate the market size of the Heparin Sodium is as follows:

History Year: 2015-2019|Base Year: 2019|Estimated Year: 2020|Forecast Year 2020 to 2024

Market Segmentation:

The global Heparin Sodium industry is separated into the fundamentals of the product, application, and region. Our prominent publisher preparing the report performs a precise and intrinsic evaluation of all segments included in the report. The necessary conserving the market share, revenue, market growth rate, and other integrated into the report. The segments are studied conscientious evaluation of all the segments model of product, application, and region. The global Heparin Sodium markets are segmented on the study recognizes high-growth divisions of the global industry and comprehend how the principal segments can thrive during the forecast period.

Primary Objectives of Heparin Sodium market Report:

The report comprises an overview of the vital geographies, market grounds in line with the production and consumption qualitative analysis, supply and demand chain, cost and revenue analysis, principal contenders, and their manufacturing plants following future estimation. The report uses SWOT and PESTLE analysis to collate market investment feasibility and return analysis.

Get Instant [emailprotected] https://www.regalintelligence.com/check-discount/107909

Table of Content

Chapter 1 About the Heparin Sodium Industry1.1 Industry Definition and Types1.1.1 Electric Type1.1.2 Hydraulic Type1.1.3 Hybrid Type1.2 Main Market Activities1.3 Similar Industries1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape2.1 Heparin Sodium Markets by Regions2.1.1 USAMarket Revenue (M USD) and Growth Rate 2015-2025Sales and Growth Rate 2015-2025Major Players Revenue (M USD) in 20192.1.2 EuropeMarket Revenue (M USD) and Growth Rate 2015-2025Sales and Growth Rate 2015-2025Major Players Revenue (M USD) in 20192.1.3 ChinaMarket Revenue (M USD) and Growth Rate 2015-2025Sales and Growth Rate 2015-2025Major Players Revenue (M USD) in 20192.1.4 IndiaMarket Revenue (M USD) and Growth Rate 2015-2025Sales and Growth Rate 2015-2025Major Players Revenue (M USD) in 20192.1.5 JapanMarket Revenue (M USD) and Growth Rate 2015-2025Sales and Growth Rate 2015-2025Major Players Revenue (M USD) in 20192.1.6 South East AsiaMarket Revenue (M USD) and Growth Rate 2015-2025Sales and Growth Rate 2015-2025Major Players Revenue (M USD) in 20192.2 World Heparin Sodium Market by TypesElectric TypeHydraulic TypeHybrid Type2.3 World Heparin Sodium Market by ApplicationsTreatment of Venous ThromboembolismComplications of PregnancyCardioversion of Atrial Fibrillation/Flutter2.4 World Heparin Sodium Market Analysis2.4.1 World Heparin Sodium Market Revenue and Growth Rate 2015-20192.4.2 World Heparin Sodium Market Consumption and Growth rate 2015-20192.4.3 World Heparin Sodium Market Price Analysis 2015-2019

Chapter 3 World Heparin Sodium Market share3.1 Major Production Market share by Players3.2 Major Revenue (M USD) Market share by Players3.3 Major Production Market share by Regions in 2019, Through 20253.4 Major Revenue (M USD) Market share By Regions in 2019, Through 2025

Chapter 4 Supply Chain Analysis4.1 Industry Supply chain Analysis4.2 Raw material Market Analysis4.2.1 Raw material Prices Analysis 2015-20194.2.2 Raw material Supply Market Analysis4.2 Manufacturing Equipment Suppliers Analysis4.3 Production Process Analysis4.4 Production Cost Structure Benchmarks4.5 End users Market Analysis

Chapter 5 Company Profiles5.1 Shenzhen Hepalink5.1.1 Company Details (Foundation Year, Employee Strength and etc)5.1.2 Product Information (Picture, Specifications and Applications)5.1.3 Revenue (M USD), Price and Operating Profits5.2 Nanjing King-friend5.2.1 Company Details (Foundation Year, Employee Strength and etc)5.2.2 Product Information (Picture, Specifications and Applications)5.2.3 Revenue (M USD), Price and Operating Profits5.3 Changzhou Qianhong Bio-pharma5.3.1 Company Details (Foundation Year, Employee Strength and etc)5.3.2 Product Information (Picture, Specifications and Applications)5.3.3 Revenue (M USD), Price and Operating Profits5.4 Changshan Biochemical5.4.1 Company Details (Foundation Year, Employee Strength and etc)5.4.2 Product Information (Picture, Specifications and Applications)5.4.3 Revenue (M USD), Price and Operating Profits5.5 Dongying Tiandong Pharmaceutical5.5.1 Company Details (Foundation Year, Employee Strength and etc)5.5.2 Product Information (Picture, Specifications and Applications)5.5.3 Revenue (M USD), Price and Operating Profits5.6 Xinbai Pharmaceuticals5.6.1 Company Details (Foundation Year, Employee Strength and etc)5.6.2 Product Information (Picture, Specifications and Applications)5.6.3 Revenue (M USD), Price and Operating Profits5.7 SPL5.7.1 Company Details (Foundation Year, Employee Strength and etc)5.7.2 Product Information (Picture, Specifications and Applications)5.7.3 Revenue (M USD), Price and Operating Profits5.8 Bioibrica5.8.1 Company Details (Foundation Year, Employee Strength and etc)5.8.2 Product Information (Picture, Specifications and Applications)5.8.3 Revenue (M USD), Price and Operating Profits5.9 Baxter5.9.1 Company Details (Foundation Year, Employee Strength and etc)5.9.2 Product Information (Picture, Specifications and Applications)5.9.3 Revenue (M USD), Price and Operating Profits5.10 Dongcheng Biochemicals5.10.1 Company Details (Foundation Year, Employee Strength and etc)5.10.2 Product Information (Picture, Specifications and Applications)5.10.3 Revenue (M USD), Price and Operating Profits5.11 Opocrin5.11.1 Company Details (Foundation Year, Employee Strength and etc)5.11.2 Product Information (Picture, Specifications and Applications)5.11.3 Revenue (M USD), Price and Operating Profits5.12 Aspen Oss5.12.1 Company Details (Foundation Year, Employee Strength and etc)5.12.2 Product Information (Picture, Specifications and Applications)5.12.3 Revenue (M USD), Price and Operating Profits5.13 Pharma Action5.13.1 Company Details (Foundation Year, Employee Strength and etc)5.13.2 Product Information (Picture, Specifications and Applications)5.13.3 Revenue (M USD), Price and Operating Profits5.14 Pfizer5.14.1 Company Details (Foundation Year, Employee Strength and etc)5.14.2 Product Information (Picture, Specifications and Applications)5.14.3 Revenue (M USD), Price and Operating Profits

Buy this Report: https://www.regalintelligence.com/buyNow/107909

To conclude, the report corroborates in decision making with the integral information and market condition to sponsor efficient business decision making to achieve goals. This report helps in making the right decision and preparation of a tactical understanding of the target market. Our research reports are provided in any kind of format (Doc, pdf, ppt, etc). The global Heparin Sodium market report is praiseworthy as it aims to be an important tool in the Heparin Sodium market analysis. Our knowledgeable industry experts have deep intelligence to analyze a market thoroughly.

Here is the original post:
Heparin Sodium Market Estimated to be driven by Innovation and Industrialization - The Daily Chronicle

Coronavirus’s Impact On Bioreactors Market Major Types, Applications, Competitive Vendors & Opportunity Forecast till 2026 – The Daily Chronicle

Posted on by

Bioreactors Industry 2020: Regulatory Scenarios, Global, Regional and Country-Level Analysis, Top Companies, Strategic Analysis By Important Product Types & Applications

A systematic research approach is implemented to derive Bioreactors Market statistics, size, revenue & share. The qualitative and quantitative Bioreactors assessment is in-line with business consultants and international research standards. Socio-economic, government rules & regulatory scenarios are considered. Bioreactors macroeconomic business environment, investment feasibility check. Product pricing & distribution is analyzed. The latest technological trends, raw materials, Bioreactors Market attractiveness, & business plans are stated. The key strategic moves, future business plans are considered to interpret the Bioreactors competition in coming years. Also, this latest report studied the COVID-19 impact on the supply chain, the revenue of companies, product demand, availability, and pricing structure.

Request Free Sample Copy of the Report (COVID-19 Impact Assessment, full TOC, Graphs, Charts):https://www.reportscheck.com/shop/global-bioreactors-market-research-report-2015-2027-of-major-types-applications-and-competitive-vendors-in-top-regions-and-countries/#sample-request

The top companies in this industry and emerging Bioreactors players are:

Bbi-biotech GmbHBellco Glass, Inc.GEA Group AktiengesellschaftMerck KGaA,General Electric Co.Medorex e.K.Bioengineering AGLAMBDA CZ, s.r.o.Lianyungang Bailun Bio-technology Co., Ltd.CerCell ApSPBS Biotech, Inc.Cellexus, Ltd.Pall Corp.CESCO Bioengineering Co. Ltd.PIERRE GUERIN SASAndel Equipment Pvt. Ltd.Applikon Biotechnology B.V.

The top product types analyzed include:

Continuous Stirred Tank BioreactorsBubble Column BioreactorAirlift BioreactorsFluidized Bed BioreactorsPhoto BioreactorsMembrane BioreactorOther

The application-level assessment include:

Monoclonal AntibodiesVaccineRecombinant ProteinsStem CellsGene Therapy

On a regional and country level, the market is classified as North America, Europe, Asia-Pacific, Middle East & Africa, South America, and rest of the world. The country-level analysis covers the United States, Canada, Mexico, China, Japan, India, South Korea, Australia, Indonesia, Philippines, Germany, France, Italy, Spain, United Kingdom, Denmark, Russia, Saudi Arabia, UAE, Turkey, Israel, Brazil, Argentina, Chile and rest. Additional countries can be included based on the users requirements.

Various parameters like direct Bioreactors competition, indirect competition, strengths, opportunities, threats are studied comprehensively. The application-wise analysis explains the availability of the total consumer base, potential customers across untapped markets. The Bioreactors value chain analysis studies the upstream suppliers, raw materials, downstream buyers, client surveys, and marketing channels.

Read Complete Table of Contents Or Receive Free Sample Report:https://www.reportscheck.com/shop/global-bioreactors-market-research-report-2015-2027-of-major-types-applications-and-competitive-vendors-in-top-regions-and-countries/#table-of-contents

The leading Bioreactors Industry performers, unique business model, latest developments, revenue, & share analysis is done. The valuable data is obtained from primary interviews with top business executives, annual reports, SEC filings, and more. The wide range of analysis including key tactics, financial investigation, and geographical study is done.

The SWOT analysis, PESTLE analysis & Porters Five Forces analysis is conducted for gauging the growth opportunities and threats. This will also help to plan fruitful Bioreactors business strategies and plans. The Bioreactors sales, pricing structure, global economy, gross margin, and market share is specified. The production rate, import-export, demand & supply scenarios are provided in detail. The market size estimation and maturity analysis are conducted.

Ask Any Query Or Make A Custom Request Here:https://www.reportscheck.com/shop/global-bioreactors-market-research-report-2015-2027-of-major-types-applications-and-competitive-vendors-in-top-regions-and-countries/

To offer you accurate and most recent Bioreactors Market situations, all our reports will be updated before dispatch by considering the pandemic impact on different industry segments. Our top-notch market reports with reports published across different industry verticals will offer a complete research solution. We aim to provide accurate market intelligence solutions to match exact customer requirements. Our expert domain-specific analyst team offers syndicate as well as custom reports.

Contact Us:

Name: Olivia Martin

Email: [emailprotected]

Organization: Reports Check

Phone: +1 (831) 679 3317

Website:www.reportscheck.com

Read more here:
Coronavirus's Impact On Bioreactors Market Major Types, Applications, Competitive Vendors & Opportunity Forecast till 2026 - The Daily Chronicle

Intestinal Organoid Built That Looks and Functions Like Real Tissue – Genetic Engineering & Biotechnology News

Posted on by

Organoids, which originate from stem cells, are a tool with great potential for modeling tissue and disease biology. The idea is to build miniature tissues and organs that accurately resemble and behave like their real counterparts. But there have been limitations to their development. A new study has taken organoids a step further by inducing intestinal stem cells to form tube-shaped epithelia with an accessible lumen and a similar spatial arrangement of crypt- and villus-like domains to that in vivo. These mini-intestines also retain key physiological hallmarks of the intestine and have a notable capacity to regenerate.

The work is published in Nature in the paper titled, Homeostatic mini-intestines through scaffold-guided organoid morphogenesis.

Organoids could complement animal testing by providing healthy or diseased human tissues, expediting the lengthy journey from lab to clinical trial. Beyond that, organoid technology may hold promise, in the long-term, to replace damaged tissues or even organs in the future. For example, by taking stem cells from a patient and growing them into a new liver, heart, kidney, or lung.

So far, established methods of making organoids come with considerable drawbacks: stem cells develop uncontrollably into circular and closed tissues that have a short lifespan, as well as non-physiological size and shape, all of which result in overall anatomical and/or physiological inconsistency with real-life organs.

Now, scientists from the group led by Matthias Ltolf, PhD, professor at EPFLs Institute of Bioengineering, have found a way to guide stem cells to form an intestinal organoid that looks and functions just like real tissue. The method exploits the ability of stem cells to grow and organize themselves along a tube-shaped scaffold that mimics the surface of the native tissue, placed inside a microfluidic chip.

The researchers used a laser to sculpt the gut-shaped scaffold within a hydrogel, a soft mix of crosslinked proteins found in the guts extracellular matrix supporting the cells in the native tissue. Aside from being the substrate on which the stem cells could grow, the hydrogel thus also provides the form or geometry that would build the final intestinal tissue.

Once seeded in the gut-like scaffold, within hours, the stem cells spread across the scaffold, forming a continuous layer of cells with its characteristic crypt structures and villus-like domains. Then came a surprising result: the scientists found that the stem cells arranged themselves in order to form a functional tiny gut.

It looks like the geometry of the hydrogel scaffold, with its crypt-shaped cavities, directly influences the behavior of the stem cells so that they are maintained in the cavities and differentiate in the areas outside, just like in the native tissue, said Ltolf. The stem cells didnt just adapt to the shape of the scaffold, they produced all the key differentiated cell types found in the real gut, with some rare and specialized cell types normally not found in organoids.

Intestinal tissues are known for the highest cell turnover rates in the body, resulting in a massive amount of shed dead cells accumulating in the lumen of the classical organoids that grow as closed spheres and require weekly breaking down into small fragments to maintain them in culture. The introduction of a microfluidic system allowed us to efficiently perfuse these mini-guts and establish a long-lived homeostatic organoid system in which cell birth and death are balanced, said Mike Nikolaev, a graduate student and the first author of the paper.

The researchers demonstrated that these miniature intestines share many functional features with their in vivo counterparts. For example, they can regenerate after massive tissue damage and they can be used to model inflammatory processes or host-microbe interactions in a way not previously possible with any other tissue model grown in the laboratory.

In addition, this approach is broadly applicable for the growth of miniature tissues from stem cells derived from other organs such as the lung, liver, or pancreas, and from biopsies of human patients. Our work, explained Ltolf, shows that tissue engineering can be used to control organoid development and build next-gen organoids with high physiological relevance, opening up exciting perspectives for disease modeling, drug discovery, diagnostics, and regenerative medicine.

See more here:
Intestinal Organoid Built That Looks and Functions Like Real Tissue - Genetic Engineering & Biotechnology News

Phenylalanine Market: Qualitative analysis of the leading players and competitive industry scenario | Ajinomoto, Daesang, KYOWA, Evonik, Amino GmbH -…

Posted on by

Phenylalanine Market Scenario 2020-2026:

The Global Phenylalanine market exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2014-2026. On the basis of historical data, Phenylalanine market report provides key segments and their sub-segments, revenue and demand & supply data. Considering technological breakthroughs of the market Phenylalanine industry is likely to appear as a commendable platform for emerging Phenylalanine market investors.

This Phenylalanine Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better.

Get Sample Report: https://grandviewreport.com/sample/58514

The complete value chain and downstream and upstream essentials are scrutinized in this report. Essential trends like globalization, growth progress boost fragmentation regulation & ecological concerns. This Market report covers technical data, manufacturing plants analysis, and raw material sources analysis of Phenylalanine Industry as well as explains which product has the highest penetration, their profit margins, and R&D status. The report makes future projections based on the analysis of the subdivision of the market which includes the global market size by product category, end-user application, and various regions.

Topmost Leading Manufacturer Covered in this report:Ajinomoto, Daesang, KYOWA, Evonik, Amino GmbH, Maidan Group, Livzon Group, Sino Sweet, Bafeng Pharmaceutical, Jinghai Amino Acid, JIRONG PHARM, Jiahe Biotech, Siwei Amino Acid, Xiyue Pharmaceutical, Dongchen Bioengineering

Product Segment Analysis: Food Grade, Pharmaceutical Grade, Feed Grade

Application Segment Analysis:

FoodMedicalFeed

Get Discount @ https://grandviewreport.com/discount/58514

Regional Analysis For PhenylalanineMarket

North America(the United States, Canada, and Mexico)Europe(Germany, France, UK, Russia, and Italy)Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)South America(Brazil, Argentina, Colombia, etc.)The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Market Synopsis:The market research report consists of extensive primary research, as well as an in-depth analysis of the qualitative and quantitative aspects by various industry specialists and professionals, to gain a deeper insight into the market and the overall landscape.

The objectives of the report are:

To analyze and forecast the market size of PhenylalanineIndustry in theglobal market. To study the global key players, SWOT analysis, value and global market share for leading players. To determine, explain and forecast the market by type, end use, and region. To analyze the market potential and advantage, opportunity and challenge, restraints and risks of global key regions. To find out significant trends and factors driving or restraining the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To critically analyze each submarket in terms of individual growth trend and their contribution to the market. To understand competitive developments such as agreements, expansions, new product launches, and possessions in the market. To strategically outline the key players and comprehensively analyze their growth strategies.

View Full Report @ https://grandviewreport.com/industry-growth/Phenylalanine-Market-58514

At last, the study gives out details about the major challenges that are going to impact market growth. They also report provides comprehensive details about the business opportunities to key stakeholders to grow their business and raise revenues in the precise verticals. The report will aid the companys existing or intend to join in this market to analyze the various aspects of this domain before investing or expanding their business in the Phenylalanine markets.

Contact Us:Grand View Report(UK) +44-208-133-9198(APAC) +91-73789-80300Email : [emailprotected]

More here:
Phenylalanine Market: Qualitative analysis of the leading players and competitive industry scenario | Ajinomoto, Daesang, KYOWA, Evonik, Amino GmbH -...

Wealth: Who are the Richest Germans? – The Berlin Spectator

Posted on by

Germany has as many as 237 billionaires on the basis of the European currency Euro. An old acquaintance is still at the top of the list.

Germanys billionaires made their fortunes by selling hygiene paper, toys, beverages, industry cables, chicken, other food, packaging, campers, software, household appliances, real estate objects and sweets. Since Germany is the land of cars, it is no surprise that the owners of quite a few car parts suppliers made it on the list of the 1,000 richest Germans published by the Welt am Sonntag weekly.

Schwarz is Undisputed Winner

The very richest German national is Dieter Schwarz. It is not the first time he made it to the top of the list, with a fortune of 41.8 billion Euro (49.5 billion U.S. Dollars or 38.3 billion Pounds Sterling). His company, Schwarz-Gruppe, with an annual turnover of 113.3 billion Euro (134.1 billion Dollars or 103.8 billion Pounds), runs ths supermarket chain Lidl and Kaufland, a big box store chains.

About half Schwarz wealth is what the second-richest Germans, the Reimann family is worth. According to the ranking compiled by Welt am Sonntag, the owners of the businesses Coty and Jacobs Douwe Egberts are sitting on 21.45 billion Euro (25.4 billion Dollars or 19.7 billion Pounds).

Porsche and BMW Shareholders

Dieter Schwarz and the Reimann family were able to increase their wealth to some extent since 2019, in spite of or maybe because of the Corona pandemic. Third on the list is Wolfgang Porsche, one of the shareholders at Volkswagen and Porsche, with a fortune of 20 billion Euro flat (23.7 billion Dollars or 18.3 billion Pounds). In Porsches case, nothing much changed since last year.

Susanne Klatten remains Germanys richest woman, with a net worth of 15.1 billion Euro (17.9 billion Dollars or 13.4 billion Pounds). She is a shareholder at both BMW and Altana, a chemicals company. Her brother Stefan Quandt only hit the 9th place on the Welt am Sonntag list. He owns 13.6 billion Euro (16.1 billion Dollars or 12.5 billion Pounds).

Places Five to Ten

Dietmar Hopp, who is on the fifth place, made his fortune with software and bioengineering. Hasso Plattner, on the sixth place, is Hopps partner at the software company SAP. He also deals with art. The seventh and eighth places are being occupied by the families Heister and Albrecht who own the supermarket chain Aldi Sd.

The tenth place goes to businessman Heinz Hermann Thiele who manufactures brakes. At the same time, he is a shareholder of several companies, including Lufthansa. The people mentioned above are only ten out of a total of 237 billionaires in Germany.

Pale in Comparison

While there obviously is a lot of wealth in the Federal Republic of Germany, those on the list still look rather pale next to the richest Americans. Jeff Bezos fortune is about three times larger than Dieter Schwarz. Bill Gates, Mark Zuckerberg, Warren Buffet, Larry Ellison, Steve Ballmer, Elon Musk, Sergey Brin, Alice Walton and several other U.S. citizens are a lot richer than Germanys number one.

The entire Welt am Sonntag list of the 1,000 richest Germans (in German) can be accessed here.

By the way:Thank you for readingThe Berlin Spectator. You can keep on doing so for free, since we do not have any paywalls and we do not intend to introduce any. Thats fine. We are glad you are here.On the other hand, if you likeThe Berlin Spectator, and if you want to support us,you can do so by clickinghere(direct Paypal link). Because of your support, we will worry less. Thank you!

See the original post:
Wealth: Who are the Richest Germans? - The Berlin Spectator

Research Roundup: Researchers test experimental COVID-19 antibodies treatment on patients – The Stanford Daily

Posted on by

Each week, The Dailys Science & Tech section produces a roundup of the most exciting and influential research happening on campus or otherwise related to Stanford. Heres our digest for the weeks of Aug 30 Sept 12.

Coronavirus antibodies treatment in phase II experimental trials

Stanford Medicine researchers are participating in a phase II multi-site clinical trial to test an antibody-drug designed to diminish early COVID-19 symptoms in patients with mild to moderate cases. Preliminary results are expected later this month.

The goal is to see if we can get sick people better faster, reducing both the length of their illness and how long they are shedding the virus, and therefore help prevent others from getting sick, Department of Emergency Medicine Chair Andra Blomkalns told Stanford Medicine News. I think this treatment shows great promise.

At Stanford Hospitals, the clinical site aims to enroll 20 to 40 patients who have tested positive for COVID-19. The experimental treatment involves using antibodies from patients who have recovered from COVID-19, then injecting these antibodies into COVID-19 positive patients.

Our hope is to effect treatment early in the course of disease, before it has time to progress further and potentially damage organs, Blomkalns said.

Microorganism yeast cells reprogrammed to produce plant-based drugs

Yeast cellular machinery can be genetically reprogrammed to change these microscopic organisms into factories that convert sugar and amino acids into plant-based drugs, a study published on Sept. 2 in Nature reports.

The drug shortages were seeing around the COVID-19 crisis drive home why we need new and more reliable ways to source these plant-based medicines, which take months to years to grow and come from a few countries, where climate change, natural disasters and geopolitical issues can disrupt supplies, bioengineering professor Christina Smolke told Stanford News.

The findings suggest that by making genetic modifications to the organelles found in yeast cells, the team can manipulate cellular processes to manufacture the desired chemical drug. In this case, researchers wanted to produce tropane alkaloid molecules for medicinal uses.

Plants are the worlds best chemists, Smolke said. We want to recapitulate their unique and useful chemistries in domesticated microbes to build complex molecules inspired by the natural world but tailored to better meet human needs.

Mosquito-borne disease likelihood increases as climate warms

In Sub-Saharan African, malaria rates are predicted to decrease, while other mosquito-borne diseases such as dengue fever, will increase significantly due to warming climates and urbanization, a study published on Sept. 9 in Lancet Planetary Health reports.

Climate change is going to rearrange the landscape of infectious disease, biology assistant professor Erin Mordecai told Stanford News. Chikungunya and dengue outbreaks like weve recently seen in East Africa are only becoming more likely across much of the continent. We need to be ready for this emerging threat.

The Aedes aegypti mosquito can transmit a wide variety of diseases, including Rift Valley Fever, yellow fever, Zika, chikungunya and dengue. The findings suggest that Aedes aegypti breeding grounds have expanded due to urbanization and warming climate. The mosquitos enjoy living in human-made water containers, like buckets or water storage tanks, and warm temperatures.

Its vital to focus on controlling mosquitoes that spread diseases like dengue because there are no medical treatments for these diseases, pediatrics professor Desiree LaBeaud told Stanford News. On top of that, a shift from malaria to dengue may overwhelm health systems because diseases introduced to new populations often lead to large outbreaks.

Contact Derek Chen at derekc8 at stanford.edu.

More here:
Research Roundup: Researchers test experimental COVID-19 antibodies treatment on patients - The Stanford Daily